SYN2

DRUG2 trials

Sponsors

Synektik S.A.

Conditions

Coronary Artery Disease

Phase 2

Absolute quantification of myocardial blood flow in human subjects with SYN2 dynamic PET imaging

RecruitingCTIS2023-507520-23-00

Synektik S.A.Coronary Artery Disease

Start: 2024-09-03Target: 30Updated: 2025-01-27

Phase 3

A Phase III Prospective, Multicenter, Open-label Study to Assess Diagnostic Efficacy of a Novel 18F-labelled Tracer, SYN2, for Positron Emission Tomography in Subjects with Suspected Coronary Artery Disease

RecruitingCTIS2023-506971-89-00

Synektik S.A.Coronary Artery Disease

Start: 2024-01-25Target: 220Updated: 2026-01-07